Photo: Alamy
President Trump’s America First agenda is winning battles on every economic front, and this week’s newest victory comes as yet another technology company has pledged to invest billions in the United States, boosting American job creation and manufacturing.
Chip manufacturer Micron Technology will invest a whopping $200 billion in U.S. semiconductor manufacturing, adding to the trillions of dollars in pledged investments already garnered by President Trump.
According to a press release from Micron, the U.S. investments will be split between domestic memory manufacturing and the construction of a “leading-edge memory fab” in Boise, Idaho, as well as the expansion of a facility in Manassas, Virginia. Additional plans include a “megafab” in New York.
“These investments are designed to allow Micron to meet expected market demand, maintain share and support Micron’s goal of producing 40% of its DRAM in the U.S. The co-location of these two Idaho fabs with Micron’s Idaho R&D operations will drive economies of scale and faster time to market for leading-edge products, including HBM,” the company stated.
This technology is aimed at meeting the demands of a rapidly evolving AI tech world, and the investment has been applauded by technology giants across the board.
“Micron’s commitment to expanding U.S. memory production marks a pivotal moment for the technology industry,” said Dell Technologies CEO and Chairman Michael Dell.
Apple CEO Tim Cook called Micron’s pledge “another great example of American manufacturing leadership” and NVIDIA founder and CEO Jensen Huang described it as a “an important step forward for the AI ecosystem.”
President Trump’s Secretary of Commerce Howard Lutnick trumpeted the achievement as an indication that the era of American investment is hotter than ever. “President Trump has made it clear that the time to build in America is now,” he said.
Micron Technology’s $200 billion investment pledge joins multi-billion-dollar investments from companies like IBM, Project Stargate, TSMC, Apple, Roche, Johnson & Johnson, and many more.